AI systems in breast imaging yield near-perfect negative predictive value but increase recall rates compared to radiologists, particularly for intermediate-risk classifications.
Key Details
- 1Study published in AJR compared Transpara v1.7.1 AI (ScreenPoint Medical) to 11 breast radiologists.
- 2Digital mammography cohort: 26,693 exams; DBT cohort: 4,824 exams.
- 3AI classified most cases as low risk but doubled or more the recall rate compared to radiologists (up to 41.8% for digital mammography at intermediate/elevated threshold).
- 4AI and radiologists both achieved NPVs of 99.8–99.9%.
- 5Sensitivity for AI at intermediate/elevated risk threshold: 94% (digital mammography), specificity fell to 58.6%.
- 6Researchers emphasized need for strategies to reduce false-positives, especially in intermediate-risk cases.
Why It Matters

Source
AuntMinnie
Related News

Landmark AI Mammography Trial and CMS Launches AI Prior Authorization Pilot
New large randomized trial to test AI in mammography screening, while CMS launches a multi-state pilot using AI for Medicare prior authorizations.

AI for Breast Cancer Screening Not Cost-Effective, Study Finds
AI-assisted breast cancer screening showed minor clinical benefits over DBT alone but was not cost-effective at standard willingness-to-pay thresholds.

AI-Generated Reports Cut Radiology Reading Times and Gain Acceptance
AI-generated reporting significantly reduces radiologists' reading times and increases report acceptability over time.